Home Data Calendar Blog

MIRM

Tables

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Common Stock Value		0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Weighted Average Number Of Diluted Shares Outstanding		46.93	NA	41.10	38.11	37.68	NA	34.93	32.18	31.30	NA	30.37	30.27
Weighted Average Number Of Shares Outstanding Basic		46.93	NA	41.10	38.11	37.68	NA	34.93	32.16	31.30	NA	30.37	NA
Earnings Per Share Basic		-0.54	-0.72	-0.57	-1.94	-0.80	-0.98	-1.02	-0.84	-1.17	NA	NA	NA
Earnings Per Share Diluted		-0.54	-0.72	-0.57	-1.94	-0.80	-0.99	-1.02	-0.84	-1.17	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Revenue From Contract With Customer Excluding Assessed Tax		69.22	69.55	47.73	37.50	31.60	27.91	18.78	17.48	12.89	3.14	5.00	11.00
Revenues		69.22	69.55	47.73	37.50	31.60	27.91	18.78	17.48	12.89	3.14	5.00	11.00
Operating Expenses		95.69	102.14	72.87	61.77	58.75	62.07	51.66	48.92	45.63	48.71	47.82	48.40
Research And Development Expense Excluding Acquired In Process Cost		32.22	30.93	26.12	22.01	23.55	31.11	26.22	25.43	24.09	27.77	30.47	35.05
Selling General And Administrative Expense		45.64	46.18	36.53	32.95	30.22	26.47	22.51	20.97	19.12	19.04	17.35	13.35
Operating Income Loss		-26.47	-32.59	-25.15	-24.27	-27.15	-34.16	-32.88	-31.44	-32.74	-45.58	-42.82	-37.40
Gains Losses On Extinguishment Of Debt		NA	0.00	0.00	-49.08	NA	NA	NA	NA	NA	NA	NA	NA
Allocated Share Based Compensation Expense		11.45	9.72	8.38	8.36	8.56	6.90	6.91	6.64	6.56	5.49	7.42	4.82
Income Tax Expense Benefit		0.62	0.23	0.25	0.32	0.20	0.14	0.01	-6.57	0.01	0.01	0.01	0.01
Income Taxes Paid Net		0.14	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Profit Loss		-25.28	-35.66	-23.59	-74.04	-30.13	-36.43	-35.71	-26.92	-36.61	57.55	-47.11	-43.89
Net Income Loss		-25.28	-35.66	-23.59	-74.04	-30.13	-36.43	-35.71	-26.92	-36.61	57.55	-47.11	-43.89
Comprehensive Income Net Of Tax		-26.94	-32.56	-25.12	-74.10	-29.78	-36.23	-35.92	-26.99	-36.70	57.52	-47.10	-43.91

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Assets		651.96	646.62	650.64	443.59	333.53	352.91	364.35	297.23	278.15	294.65	235.17	247.67
Liabilities		417.36	397.95	381.56	364.98	192.38	210.87	195.05	186.55	169.22	174.44	178.77	151.93
Liabilities And Stockholders Equity		651.96	646.62	650.64	443.59	333.53	352.91	364.35	297.23	278.15	294.65	235.17	247.67
Stockholders Equity		234.60	248.67	269.08	78.61	141.15	142.04	169.30	110.69	108.93	120.21	56.40	95.74

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Assets Current		389.46	387.54	388.58	383.52	172.33	190.22	215.56	147.25	155.27	166.59	196.81	228.37
Cash And Cash Equivalents At Carrying Value		302.84	286.33	303.06	297.23	49.42	28.00	35.76	55.27	46.27	31.34	55.84	91.94
Accounts Receivable Net Current		55.00	67.97	47.83	35.33	24.66	23.99	16.34	13.99	7.87	3.27	NA	NA
Inventory Net		21.61	22.31	22.25	8.51	6.61	5.57	6.94	4.52	1.58	1.51	NA	NA
Inventory Finished Goods		7.87	9.44	11.28	1.54	0.13	0.21	0.18	0.24	0.17	0.09	NA	NA
Inventory Raw Materials And Supplies		2.89	3.00	0.44	NA	NA	NA	NA	NA	0.86	0.86	NA	NA
Prepaid Expense And Other Assets Current		10.02	10.94	12.46	9.73	8.99	8.95	6.93	3.78	5.91	5.27	6.37	4.51

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		NA	1.50	NA	NA	NA	1.00	NA	NA	NA	0.00	NA	NA
Amortization Of Intangible Assets		5.50	5.40	2.60	1.30	1.30	1.10	1.00	0.50	0.00	NA	NA	NA
Property Plant And Equipment Net		0.50	0.71	0.79	0.87	0.88	0.91	0.80	0.83	0.90	0.98	1.06	1.13
Intangible Assets Net Excluding Goodwill		257.44	252.93	258.34	56.44	57.70	58.95	45.03	46.07	18.48	18.74	19.00	NA
Finite Lived Intangible Assets Net		257.44	252.93	258.34	56.44	57.70	58.95	45.03	46.07	18.48	18.74	NA	NA
Other Assets Noncurrent		3.87	4.17	1.51	1.15	1.34	1.38	1.71	1.72	2.03	1.79	1.64	1.43

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Liabilities Current		105.91	87.06	74.66	58.20	48.84	64.73	51.40	45.17	34.55	42.60	50.39	29.03
Accounts Payable Current		15.98	7.42	7.37	14.45	6.44	8.69	10.55	8.12	4.94	9.17	5.00	5.38
Accrued Liabilities Current		89.57	78.54	66.21	42.69	40.40	54.02	38.31	34.54	26.88	30.72	43.85	20.77

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Other Liabilities Noncurrent		4.29	3.85	0.01	0.01	0.77	4.53	4.32	4.14	0.01	0.02	0.02	0.02
Operating Lease Liability Noncurrent		0.33	0.62	0.87	1.15	1.05	1.26	1.31	1.52	1.71	1.90	2.09	2.27

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Stockholders Equity		234.60	248.67	269.08	78.61	141.15	142.04	169.30	110.69	108.93	120.21	56.40	95.74
Common Stock Value		0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Additional Paid In Capital Common Stock		816.13	803.26	791.11	575.52	563.96	535.07	526.10	431.57	402.82	377.40	371.10	363.34
Retained Earnings Accumulated Deficit		-581.52	-556.24	-520.58	-496.99	-422.95	-392.82	-356.39	-320.69	-293.76	-257.16	-314.70	-267.60
Accumulated Other Comprehensive Income Loss Net Of Tax		-0.01	1.64	-1.46	0.08	0.14	-0.22	-0.41	-0.20	-0.13	-0.04	-0.01	-0.01
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		11.66	NA	8.59	8.56	8.73	NA	7.07	6.82	6.56	NA	7.42	4.82

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Net Cash Provided By Used In Operating Activities		15.21	-16.62	-18.22	-2.33	-33.77	-34.27	-26.02	-20.17	-39.67	-33.15	-34.20	-40.20
Net Cash Provided By Used In Investing Activities		-0.01	-2.00	-182.76	35.55	42.02	26.76	-79.53	23.97	36.50	108.02	-2.24	-24.45
Net Cash Provided By Used In Financing Activities		1.21	1.78	207.13	114.71	12.99	-0.33	86.07	5.25	18.10	0.61	0.34	65.91

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Net Cash Provided By Used In Operating Activities		15.21	-16.62	-18.22	-2.33	-33.77	-34.27	-26.02	-20.17	-39.67	-33.15	-34.20	-40.20
Net Income Loss		-25.28	-35.66	-23.59	-74.04	-30.13	-36.43	-35.71	-26.92	-36.61	57.55	-47.11	-43.89
Profit Loss		-25.28	-35.66	-23.59	-74.04	-30.13	-36.43	-35.71	-26.92	-36.61	57.55	-47.11	-43.89
Depreciation Depletion And Amortization		5.66	5.49	2.66	1.34	1.34	1.20	1.10	0.60	0.34	0.34	0.08	0.08
Increase Decrease In Accounts Receivable		-12.97	20.13	12.51	10.66	0.67	7.66	2.35	6.12	4.61	NA	NA	NA
Increase Decrease In Inventories		3.17	2.19	0.44	0.99	0.78	-0.60	2.80	1.18	0.07	NA	NA	NA
Share Based Compensation		11.45	9.72	8.38	8.36	8.56	6.90	6.73	6.82	6.56	5.56	7.42	4.82

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Net Cash Provided By Used In Investing Activities		-0.01	-2.00	-182.76	35.55	42.02	26.76	-79.53	23.97	36.50	108.02	-2.24	-24.45
Payments To Acquire Property Plant And Equipment		0.01	0.00	0.00	0.07	0.04	0.24	0.02	NA	NA	0.00	0.02	0.00
Payments To Acquire Investments		NA	0.00	0.00	4.88	22.44	0.00	117.51	NA	NA	18.97	49.72	45.95

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Net Cash Provided By Used In Financing Activities		1.21	1.78	207.13	114.71	12.99	-0.33	86.07	5.25	18.10	0.61	0.34	65.91

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
Revenues		69.22	69.55	47.73	37.50	31.60	27.91	18.78	17.48	12.89	3.14	5.00	11.00
Revenue From Contract With Customer Excluding Assessed Tax		69.22	69.55	47.73	37.50	31.60	27.91	18.78	17.48	12.89	3.14	5.00	11.00
Bile Acid Medicines		26.07	28.06	9.02	NA	NA	NA	NA	NA	NA	NA	NA	NA
License And Other Revenue		0.30	NA	NA	NA	2.50	NA	NA	NA	NA	NA	NA	NA
Livmarli		42.84	41.49	38.71	NA	29.10	27.91	18.78	NA	NA	NA	NA	NA
License		NA	0.00	0.00	5.00	2.50	0.00	0.00	0.00	2.00	0.00	5.00	11.00
Product		68.92	69.55	47.73	32.50	29.10	27.91	18.78	17.48	10.89	NA	NA	NA
Product,US		56.11	NA	NA	NA	24.61	NA	NA	NA	NA	NA	NA	NA
Product, Rest Of World		12.81	NA	NA	NA	4.48	NA	NA	NA	NA	NA	NA	NA

Plots across concepts

Line plots across dimensions of each concept